News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
215 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
EyeGate Completes Enrollment in Phase IIb Clinical Trial of EGP-437 for Cataract Surgery
Topline data is expected to be released in the first quarter of 2018.
November 8, 2017
·
4 min read
Policy
Fortress Biotech Announces Cellvation’s CEVA101 Granted FDA Regenerative Medicine Advanced Therapy Designation for the Treatment of Traumatic Brain Injury
CEVA101 is being developed in partnership with The University of Texas Health Science Center at Houston.
November 8, 2017
·
7 min read
Business
Tyme Provides Clinical and Corporate Update for the Fiscal First Half 2017
Investor conference call scheduled for 10 am ET today.
November 8, 2017
·
8 min read
Business
G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights
Operating expenses were $15.9 million for the third quarter of 2017, compared to $6.6 million for the third quarter of 2016.
November 8, 2017
·
7 min read
Business
G1 Therapeutics Makes Key Executive Appointments
The company appointed Barclay (Buck) Phillips as CFO and Sr. VP, Corporate Development, and Chandra Lovejoy as VP, Global Regulatory Affairs.
November 8, 2017
·
5 min read
Business
Axsome Therapeutics Reports Third Quarter 2017 Financial Results
As of September 30, 2017, Axsome had $31.7 million of cash compared to $36.6 million of cash as of December 31, 2016.
November 8, 2017
·
10 min read
Business
Neos Therapeutics Reports Third Quarter 2017 Financial Results
Total product revenues were $6.7 million for the three months ended September 30, 2017, compared to $1.6 million for the same period in 2016.
November 8, 2017
·
11 min read
Business
Paratek Pharmaceuticals Reports Third Quarter 2017 Financial Results, Remains on Track to Complete NDA Submissions in First Quarter of 2018
Paratek reported a net loss of $21.3 million, or ($0.77) per share, for the quarter ended September 30, 2017 compared to a net loss of $23.6 million, or ($1.04) per share, for the same period in 2016.
November 8, 2017
·
8 min read
Drug Development
Nightstar Expands Pipeline With Novel Gene Therapy for the Treatment of Stargardt Disease
Stargardt disease is the most common form of inherited juvenile macular dystrophy with a prevalence of one in 10,000.
November 8, 2017
·
5 min read
Arocell AB: Abstract Published Presenting Arocell TK 210 ELISA From the PROMIX Study at the European Society for Medical Oncology Congress in Singapore, November 17-19, 2017
The investigators quantified cell loss using the AroCell TK 210 ELISA kit to measure serum TK1 in serial samples from 145 breast cancer patients undergoing chemotherapy before surgery.
November 8, 2017
·
2 min read
Previous
6 of 22
Next